Michael Plank, University of Canterbury; Shaun Hendy, University of Auckland, and Siouxsie Wiles, University of …
Read More »AFT Pharmaceuticals confirms dual-listing plans to fund R&D, global growth
AFT Pharmaceuticals, the Auckland-based drugs developer and reseller, wants to list in Australia and New Zealand, raising funds to speed up the development of products to sell in other countries. The company is considering an initial public offering on the NZX and ASX, hiring First NZ Capital as sole lead manager, it said in a statement, without indicating how much money it …
Read More »
newzealandinc.com Informed. Influential. Indispensable.






